Anuh Pharma Ltd.
NSE: ANUHPHR BSE: ANUHPHR
Prev Close
80.88
Open Price
81
Volume
25,959
Today Low / High
79.36 / 81.4
52 WK Low / High
74.25 / 122.85
Range
77 - 85
Prev Close
80.59
Open Price
83
Volume
2,774
Today Low / High
79.9 / 83
52 WK Low / High
74.025 / 121
Range
77 - 85
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 81 (target range: 77 - 85), reflecting a change of 0.12 (0.14837%). On the BSE, it is listed at 80.63 (target range: 77 - 85), showing a change of 0.04 (0.04963395%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Anuh Pharma Ltd. Graph
Anuh Pharma Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Anuh Pharma Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 81.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 80.63 | 81.44 | 73.29 - 89.58 |
| 82.24 | 65.79 - 98.69 | ||
| 83.05 | 58.13 - 107.96 | ||
| Bearish Scenario | 80.63 | 79.82 | 71.84 - 87.81 |
| 79.02 | 63.21 - 94.82 | ||
| 78.21 | 54.75 - 101.67 |
Overview of Anuh Pharma Ltd.
ISIN
INE489G01022
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
58,686
Market Cap
8,118,144,000
Last Dividend
1.5
Official Website
IPO Date
2024-12-20
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
No financial ratio data available.
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial income report data available. | |||||||||||
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial balance sheet data available. | ||||||||||||
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial cash flow statement data available. | |||||||||||
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial income report data available. | |||||||||
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial balance sheet data available. | |||||||||
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,776.60 | ₹4,262,658,507,702.00 | ₹880,438.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,450.00 | ₹1,712,272,341,000.00 | ₹82,909.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,748.00 | ₹1,268,493,509,120.00 | ₹73,069.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,245.00 | ₹1,036,478,093,625.00 | ₹462,585.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹932.00 | ₹937,810,078,680.00 | ₹389,988.00 |
| Lupin Limited | LUPIN | ₹2,031.10 | ₹927,729,663,798.00 | ₹341,250.00 |
| Mankind Pharma Limited | MANKIND | ₹2,222.30 | ₹917,273,192,327.00 | ₹148,596.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,234.70 | ₹717,115,763,918.00 | ₹340,329.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,737.00 | ₹685,944,405,000.00 | ₹55,028.00 |
| Laurus Labs Limited | LAURUSLABS | ₹988.80 | ₹533,778,860,131.00 | ₹888,608.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,849.70 | ₹521,986,836,407.00 | ₹414,857.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,426.20 | ₹361,832,955,712.00 | ₹203,156.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,507.40 | ₹313,263,583,618.00 | ₹27,792.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,771.30 | ₹277,378,494,800.00 | ₹70,348.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,380.20 | ₹261,637,401,829.00 | ₹313,000.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,969.00 | ₹224,225,000,000.00 | ₹5,325.00 |
| Cohance Lifesciences Limited | COHANCE | ₹579.85 | ₹221,831,556,129.00 | ₹1,288,062.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹17,085.00 | ₹219,198,653,565.00 | ₹16,421.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,341.00 | ₹217,901,998,629.00 | ₹104,322.00 |
| Eris Lifesciences Limited | ERIS | ₹1,596.70 | ₹217,492,181,672.00 | ₹69,273.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹907.15 | ₹178,312,237,937.00 | ₹39,362.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,119.60 | ₹177,454,847,826.00 | ₹45,307.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹832.45 | ₹149,100,011,282.00 | ₹1,996,481.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,927.70 | ₹146,527,746,379.00 | ₹27,913.00 |
| Granules India Limited | GRANULES | ₹554.55 | ₹134,571,936,458.00 | ₹265,057.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹911.95 | ₹111,879,255,309.00 | ₹336,074.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,900.00 | ₹97,936,353,800.00 | ₹4,344.00 |
| Strides Pharma Science Limited | STAR | ₹968.90 | ₹89,306,142,595.00 | ₹229,969.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹360.20 | ₹70,448,570,123.00 | ₹153,388.00 |
| FDC Limited | FDC | ₹408.45 | ₹66,499,778,810.00 | ₹76,139.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹422.85 | ₹64,739,205,225.00 | ₹193,690.00 |
| Sequent Scientific Limited | SEQUENT | ₹254.81 | ₹63,657,607,319.00 | ₹7,219,486.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹701.20 | ₹63,561,882,553.00 | ₹257,651.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹421.30 | ₹45,907,066,145.00 | ₹99,173.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹851.20 | ₹43,172,102,176.00 | ₹62,718.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹130.36 | ₹42,304,634,212.00 | ₹104,837.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹458.00 | ₹41,801,660,000.00 | ₹102,109.00 |
| Innova Captab Limited | INNOVACAP | ₹727.50 | ₹41,631,135,848.00 | ₹8,956.00 |
| Suven Life Sciences Limited | SUVEN | ₹177.46 | ₹39,113,251,422.00 | ₹52,404.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,252.80 | ₹37,259,092,992.00 | ₹26,082.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹485.00 | ₹34,146,788,750.00 | ₹66,550.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹338.75 | ₹33,970,698,908.00 | ₹116,187.00 |
Key Executives
Gender: male
Year Born: 1949
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1981
Gender: male
Year Born: 1986
FAQs about Anuh Pharma Ltd.
The CEO is Ritesh Bipin Shah MBA.
The current price is ₹81.00.
The range is ₹74.25-122.85.
The market capitalization is ₹811.81 crores.
The company operates in the Healthcare sector.
Overview of Anuh Pharma Ltd. (ISIN: INE489G01022) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹811.81 crores and an average daily volume of 58,686 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.5.